313 related articles for article (PubMed ID: 30126705)
1. Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice.
Ferrières J; Gorcyca K; Iorga ŞR; Ansell D; Steen DL
Clin Ther; 2018 Sep; 40(9):1484-1495.e22. PubMed ID: 30126705
[TBL] [Abstract][Full Text] [Related]
2. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
[TBL] [Abstract][Full Text] [Related]
3. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.
Wang X; He Y; Wang T; Li C; Ma Z; Zhang H; Ma H; Zhao H
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):307-315. PubMed ID: 31918567
[TBL] [Abstract][Full Text] [Related]
4. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
5. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
[TBL] [Abstract][Full Text] [Related]
6. Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.
Steen DL; Khan I; Becker L; Foody JM; Gorcyca K; Sanchez RJ; Giugliano RP
Clin Cardiol; 2017 Mar; 40(3):155-162. PubMed ID: 28026031
[TBL] [Abstract][Full Text] [Related]
7. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
[TBL] [Abstract][Full Text] [Related]
8. Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular Disease.
Cannon CP; Khan I; Klimchak AC; Reynolds MR; Sanchez RJ; Sasiela WJ
JAMA Cardiol; 2017 Sep; 2(9):959-966. PubMed ID: 28768335
[TBL] [Abstract][Full Text] [Related]
9. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and treatment patterns in patients with atherosclerotic cardiovascular disease with hypercholesterolemia: a retrospective analysis of a large US real-world database cohort.
Lahoz R; Seshagiri D; Electricwala B; Achouba A; Ding Y; Heo JH; Cristino J; Studer R
Curr Med Res Opin; 2024 Jan; 40(1):15-25. PubMed ID: 37941428
[TBL] [Abstract][Full Text] [Related]
11. 2017 Taiwan lipid guidelines for high risk patients.
Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
[TBL] [Abstract][Full Text] [Related]
13. Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study.
Ersbøll AK; Kristensen MS; Nybo M; Hede SM; Mikkelsen KH; Gislason G; Lytken Larsen M; Green A
PLoS One; 2023; 18(5):e0286376. PubMed ID: 37256879
[TBL] [Abstract][Full Text] [Related]
14. Disparities in lipid control and statin drug use among diabetics with noncoronary atherosclerotic vascular disease vs those with coronary artery disease.
Thapa R; Sharma S; Jeevanantham V; Hu C; Myers T; Vacek JL; Dawn B; Gupta K
J Clin Lipidol; 2015; 9(2):241-6. PubMed ID: 25911081
[TBL] [Abstract][Full Text] [Related]
15. Unused potential of lipid-lowering therapy in very high-risk patients with atherosclerotic cardiovascular disease. A retrospective data analysis.
Pohl SB; Engelbertz C; Reinecke H; Malyar NM; Meyborg M; Brix TJ; Varghese J; Gebauer K
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1670-1680. PubMed ID: 38664125
[TBL] [Abstract][Full Text] [Related]
16. Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease.
Chamberlain AM; Cohen SS; Killian JM; Monda KL; Weston SA; Okerson T
Am J Cardiol; 2019 Oct; 124(7):995-1001. PubMed ID: 31362878
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.
Fox KM; Tai MH; Kostev K; Hatz M; Qian Y; Laufs U
Clin Res Cardiol; 2018 May; 107(5):380-388. PubMed ID: 29273856
[TBL] [Abstract][Full Text] [Related]
18. Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus.
Rana JS; Liu JY; Moffet HH; Boklage SH; Khan I; Karter AJ
Am J Cardiol; 2018 Sep; 122(5):762-767. PubMed ID: 30057224
[TBL] [Abstract][Full Text] [Related]
19. Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome.
Wongsalap Y; Jedsadayanmata A
J Cardiol; 2020 Mar; 75(3):275-281. PubMed ID: 31519405
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta.
Chen G; Farris MS; Cowling T; Colgan SM; Xiang P; Pericleous L; Rogoza RM; Tai MH; Anderson T
Can J Cardiol; 2019 Jul; 35(7):884-891. PubMed ID: 31292087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
